Meenakshi Bhalla is a Cardiology physician. OpenAlex indexes 49 publications with 2,873 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3003 W Dr Martin Luther King Jr Blvd Fl 2
Tampa, FL 336076307
Telephone
813-397-1251Provider last certified this registry record 2 Sept 2025.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20253 payments
- Abbott LaboratoriesProgram year20252 payments
- CVRx, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.2%Beta blocker17%Metoprolol Succinate65%Carvedilol18%Bisoprolol Fumarate17%Part D≥41 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)16.5%Entresto100%Part D≥45 patients+ 10 more classes in this area
Metabolism & gastrointestinal
13.4%SGLT2 inhibitor11.8%Farxiga52%Jardiance49%Part D≥21 patientsProton pump inhibitor1.6%Pantoprazole Sodium100%Part D<11 patientsBlood & clotting
11.5%Vitamin K antagonist4.5%Warfarin Sodium100%Part D≥12 patientsFactor Xa inhibitor4%Eliquis71%Xarelto29%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Contemporary Meta-Analysis of Extended Direct-Acting Oral Anticoagulant Thromboprophylaxis to Prevent Venous Thromboembolism
The American Journal of Medicine
2020 - Abstract 14870: Meta-Analysis of the Efficacy, Safety and Cost-Benefit of Direct Oral Anticoagulation for Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients Post-Hospitalization
Circulation
2019 - Serum potassium predicts time to blood pressure response among African Americans with hypertensive nephrosclerosis
Journal of Human Hypertension
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”